Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$5.05 USD
+0.06 (1.20%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.02 -0.03 (-0.59%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.34 | 0.00% |
Earnings Summary
For their last quarter, Capricor Therapeutics (CAPR) reported earnings of -$0.35 per share, missing the Zacks Consensus Estimate of -$0.32 per share. This reflects a negative earnings surprise of 9.38%. Look out for CAPR's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.34 per share, reflecting a year-over-year decrease of 36%.
Earnings History
Price & Consensus
Zacks News for CAPR
Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings Estimates
CAPR: What are Zacks experts saying now?
Zacks Private Portfolio Services